Publications
81
Citations
840
Est. group size
~3
Recurring co-author estimate
Active years
18
Publishing since 2009
Bhuvana A. Setty's work focuses on pediatric and young-adult bone and soft-tissue cancers, especially Ewing sarcoma and osteosarcoma, with an emphasis on developing and testing new drug treatments through clinical trials. Much of this research involves multi-institutional collaborations (such as the Children's Oncology Group and the National Pediatric Cancer Foundation) that evaluate chemotherapy combinations, targeted agents, and antibody-drug conjugates, alongside biomarker approaches like liquid biopsy (blood-based tumor DNA testing) to monitor treatment response.
Publication output has grown from roughly 3-4 papers per year around 2017-2019 to a higher, somewhat variable pace of 10-12 papers per year in 2020-2024, indicating an overall increase in activity over the last decade.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee
Pediatric Blood & Cancer · 2025
- 523 Median OS of 21.5 months among 44 patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma treated with mecbotamab vedotin, an AXL-targeting ADC
Regular and Young Investigator Award Abstracts · 2025
- 53O Results from a phase II part I trial of mecbotamab vedotin (BA3011), a CAB-AXL-ADC, in patients with advanced refractory sarcoma
ESMO Open · 2024
- Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation
Clinical Cancer Research · 2024
- Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
Pediatric Blood & Cancer · 2024
- Prospective evaluation of pre-treatment ctDNA burden in localized osteosarcoma to identify patients with inferior outcomes: A report from the LEOPARD study.
Journal of Clinical Oncology · 2024
- Supplementary Table S1 from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation
2024
- Data from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation
2024
- Supplementary Table S2 from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation
2024
- Supplementary Table S3 from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation
2024
- Abstract 377: Prevalence and Radiological Manifestations of Jugular Venous Stenosis in Patients with Pulsatile Tinnitus: A Case‐Control Study
Stroke Vascular and Interventional Neurology · 2024
- Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study
Pediatric Blood & Cancer · 2023
- Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents
Pediatric Drugs · 2023
- Treatment practices and response in Kaposiform hemangioendothelioma: a multi-center cohort study
2023
- Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas
European Journal of Cancer · 2022
- Pediatric Blood & Cancer×10
- Journal of Clinical Oncology×8
- Journal of Pediatric Hematology/Oncology×4
- Neuro-Oncology×2
- Research Square×2
- Michael J. Ferguson
Medicine · Indiana University
- Ryan D. Roberts
Medicine · The Ohio State University
- Karen E. Pollok
Medicine · Indiana University
- M. Reza Saadatzadeh
Medicine · Indiana University
- Pankita H. Pandya
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile